These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 8429455

  • 1. Dextromethorphan in infantile nonketotic hyperglycinemia.
    Schmitt B, Steinmann B.
    J Pediatr; 1993 Feb; 122(2):324-5. PubMed ID: 8429455
    [No Abstract] [Full Text] [Related]

  • 2. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
    Hamosh A, McDonald JW, Valle D, Francomano CA, Niedermeyer E, Johnston MV.
    J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
    [Abstract] [Full Text] [Related]

  • 3. Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor.
    Schmitt B, Steinmann B, Gitzelmann R, Thun-Hohenstein L, Mascher H, Dumermuth G.
    Neurology; 1993 Feb; 43(2):421-4. PubMed ID: 8437713
    [Abstract] [Full Text] [Related]

  • 4. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A, Maher JF, Bellus GA, Rasmussen SA, Johnston MV.
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic trial of NMDA antagonist for a nonketotic hyperglycinemic infant].
    Imai M, Kitajima H, Tokoro T, Kubo M, Maekawa K.
    No To Hattatsu; 1995 Jul; 27(4):327-9. PubMed ID: 7612297
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia.
    Alemzadeh R, Gammeltoft K, Matteson K.
    Pediatrics; 1996 Jun; 97(6 Pt 1):924-6. PubMed ID: 8657542
    [Abstract] [Full Text] [Related]

  • 7. Dextromethorphan in nonketotic hyperglycinemia.
    Allen RJ.
    Neurology; 1993 Nov; 43(11):2422-3. PubMed ID: 8110239
    [No Abstract] [Full Text] [Related]

  • 8. Dextrorphan, but not dextromethorphan, exerts weak antidystonic effects in mutant dystonic hamsters.
    Richter A, Löscher W.
    Brain Res; 1997 Jan 16; 745(1-2):336-8. PubMed ID: 9037429
    [Abstract] [Full Text] [Related]

  • 9. Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia.
    Viola A, Chabrol B, Nicoli F, Confort-Gouny S, Viout P, Cozzone PJ.
    Pediatr Res; 2002 Aug 16; 52(2):292-300. PubMed ID: 12149509
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia.
    Bjoraker KJ, Swanson MA, Coughlin CR, Christodoulou J, Tan ES, Fergeson M, Dyack S, Ahmad A, Friederich MW, Spector EB, Creadon-Swindell G, Hodge MA, Gaughan S, Burns C, Van Hove JL.
    J Pediatr; 2016 Mar 16; 170():234-9. PubMed ID: 26749113
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
    Chien YH, Hsu CC, Huang A, Chou SP, Lu FL, Lee WT, Hwu WL.
    J Child Neurol; 2004 Jan 16; 19(1):39-42. PubMed ID: 15032382
    [Abstract] [Full Text] [Related]

  • 14. Nonketotic hyperglycinemia: treatment with NMDA antagonist and consideration of neuropathogenesis.
    Ohya Y, Ochi N, Mizutani N, Hayakawa C, Watanabe K.
    Pediatr Neurol; 1991 Jan 16; 7(1):65-8. PubMed ID: 1827585
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of dextromethorphan and cyclosporine a for acute encephalopathy.
    Matsuo M, Maeda T, Ono N, Sugihara S, Kobayashi I, Koga D, Hamasaki Y.
    Pediatr Neurol; 2013 Mar 16; 48(3):200-5. PubMed ID: 23419470
    [Abstract] [Full Text] [Related]

  • 16. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia.
    Zammarchi E, Donati MA, Ciani F, Pasquini E, Pela I, Fiorini P.
    Neuropediatrics; 1994 Oct 16; 25(5):274-6. PubMed ID: 7885541
    [Abstract] [Full Text] [Related]

  • 17. Treatment with the N-methyl-D-aspartate receptor antagonist dextromethorphan in severe bacterial meningitis: preliminary results.
    Schmitt B, Wohlrab G, Steinlin M, Fanconi S, Nadal D, Boltshauser E.
    Eur J Pediatr; 1998 Oct 16; 157(10):863-5. PubMed ID: 9809832
    [No Abstract] [Full Text] [Related]

  • 18. Dextromethorphan in a child with nonketotic hyperglycinaemia--a 6-year follow up.
    Schmitt B, Steinmann B.
    Eur J Pediatr; 1998 Apr 16; 157(4):349-50. PubMed ID: 9578977
    [No Abstract] [Full Text] [Related]

  • 19. Use of Perampanel and a Ketogenic Diet in Nonketotic Hyperglycinemia: A Case Report.
    Daida A, Hamano SI, Ikemoto S, Hirata Y, Matsuura R, Koichihara R, Oba D, Ohashi H.
    Neuropediatrics; 2020 Dec 16; 51(6):417-420. PubMed ID: 32176929
    [Abstract] [Full Text] [Related]

  • 20. Late-onset nonketotic hyperglycinemia caused by a novel homozygous missense mutation in the GLDC gene.
    Brunel-Guitton C, Casey B, Coulter-Mackie M, Vallance H, Hewes D, Stockler-Ipsiroglu S, Mercimek-Mahmutoglu S.
    Mol Genet Metab; 2011 Jun 16; 103(2):193-6. PubMed ID: 21411353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.